Ursodeoxycholic acid ameliorates cell migration retarded by the SARS-CoV-2 spike protein in BEAS-2B human bronchial epithelial cells.
Saved in:
| Title: | Ursodeoxycholic acid ameliorates cell migration retarded by the SARS-CoV-2 spike protein in BEAS-2B human bronchial epithelial cells. |
|---|---|
| Authors: | Thuy PX; Department of Integrated Bioscience and Biotechnology, Seoul 05006, Republic of Korea., Bao TDD; Department of Integrated Bioscience and Biotechnology, Seoul 05006, Republic of Korea., Moon EY; Department of Integrated Bioscience and Biotechnology, Seoul 05006, Republic of Korea. Electronic address: eunyimoon@sejong.ac.kr. |
| Source: | Biomedicine & pharmacotherapy = Biomedecine & pharmacotherapie [Biomed Pharmacother] 2022 Jun; Vol. 150, pp. 113021. Date of Electronic Publication: 2022 Apr 25. |
| Publication Type: | Journal Article |
| Journal Info: | Publisher: Editions Scientifiques Elsevier Country of Publication: France NLM ID: 8213295 Publication Model: Print-Electronic Cited Medium: Internet ISSN: 1950-6007 (Electronic) Linking ISSN: 07533322 NLM ISO Abbreviation: Biomed Pharmacother Subsets: MEDLINE |
| Database: | MEDLINE Ultimate |
Be the first to leave a comment!
